Cargando…
The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma
BACKGROUND AND OBJECTIVES: The nuclear factor kappa B (NF-κB) signaling is activated in esophageal squamous cell carcinoma (ESCC) and can be used as a potential target for anti-ESCC drug discovery. In this study, we aimed to investigate the function of flubendazole as a novel NF-κB inhibitor in ESCC...
Autores principales: | Tao, Jiali, Zhao, Hongmei, Xie, Xiaochen, Luo, Man, Gao, Zhiwei, Sun, Hong, Huang, Ziming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331185/ https://www.ncbi.nlm.nih.gov/pubmed/30666126 http://dx.doi.org/10.2147/OTT.S193206 |
Ejemplares similares
-
Toxicity of anthelmintic drugs (fenbendazole and flubendazole) to aquatic organisms
por: Wagil, Marta, et al.
Publicado: (2014) -
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
por: Hou, Zhi-Jie, et al.
Publicado: (2015) -
Investigating Flubendazole as an Anthelmintic Treatment for Guinea Worm (Dracunculus medinensis): Clinical Trials in Laboratory-Reared Ferrets and Domestic Dogs in Chad
por: Cleveland, Christopher A., et al.
Publicado: (2022) -
Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis
por: Zhou, Xumin, et al.
Publicado: (2018) -
Flubendazole as a macrofilaricide: History and background
por: Geary, Timothy G., et al.
Publicado: (2019)